These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 23453645)
1. Efficacy of two fluorescence in situ hybridization (FISH) probes for diagnosing malignant pleural effusions. Rosolen DC; Kulikowski LD; Bottura G; Nascimento AM; Acencio M; Teixeira L; Vargas FS; Sales RK; Antonangelo L Lung Cancer; 2013 Jun; 80(3):284-8. PubMed ID: 23453645 [TBL] [Abstract][Full Text] [Related]
2. [The negative enrichment by immunomagnetic beads for tumor cells from malignant pleural effusions]. Yang JJ; Xu XX; Min LF; Lin P; Qian GS Zhonghua Jie He He Hu Xi Za Zhi; 2012 Sep; 35(9):673-8. PubMed ID: 23158070 [TBL] [Abstract][Full Text] [Related]
3. Detection of hyperdiploid malignant cells in pleural effusions with chromosome-specific probes and fluorescence in situ hybridization. Johnson TM; Kuffel DG; Dewald GW Mayo Clin Proc; 1996 Jul; 71(7):643-8. PubMed ID: 8656705 [TBL] [Abstract][Full Text] [Related]
4. [Study on interphase cytogenetic abnormalities in malignant cells in pleural fluids from lung cancer cases]. Jia D; Zhang Z; Liu S; Cheng S Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):244-7. PubMed ID: 10932006 [TBL] [Abstract][Full Text] [Related]
5. Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions. Han J; Cao S; Zhang K; Zhao G; Xin Y; Dong Q; Yan Y; Cui J J Cardiothorac Surg; 2012 Nov; 7():121. PubMed ID: 23148562 [TBL] [Abstract][Full Text] [Related]
6. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology. Matsumoto S; Nabeshima K; Kamei T; Hiroshima K; Kawahara K; Hata S; Marukawa K; Matsuno Y; Taguchi K; Tsujimura T Cancer Cytopathol; 2013 Aug; 121(8):415-22. PubMed ID: 23450849 [TBL] [Abstract][Full Text] [Related]
7. Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids. Nieh S; Chen SF; Fu E; Jan CI; Lee WH Acta Cytol; 2005; 49(1):31-7. PubMed ID: 15717752 [TBL] [Abstract][Full Text] [Related]
8. Performance of the UroVysion Rosolen DCB; Faria DK; Faria CS; Antonangelo L Cancer Med; 2018 May; 7(5):1967-1977. PubMed ID: 29577646 [TBL] [Abstract][Full Text] [Related]
9. Detection of hyperdiploid malignant cells in body cavity effusions by fluoresence in situ hybridization on ThinPrep slides. Florentine BD; Sanchez B; Raza A; Frankel K; Martin SE; Kovacs B; Felix JC Cancer; 1997 Oct; 81(5):299-308. PubMed ID: 9349518 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of human telomerase reverse transcriptase mRNA in malignant pleural effusions: A preliminary report for in situ hybridization detection. Shu J; Sun GY; Liu AP; Liu J Clin Chim Acta; 2007 Jun; 381(2):131-5. PubMed ID: 17399696 [TBL] [Abstract][Full Text] [Related]
11. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions. Flores-Staino C; Darai-Ramqvist E; Dobra K; Hjerpe A Lung Cancer; 2010 Apr; 68(1):39-43. PubMed ID: 19523712 [TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology. Savic S; Franco N; Grilli B; Barascud Ade V; Herzog M; Bode B; Loosli H; Spieler P; Schönegg R; Zlobec I; Clark DP; Herman JG; Bubendorf L Chest; 2010 Jul; 138(1):137-44. PubMed ID: 20139227 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634 [TBL] [Abstract][Full Text] [Related]
14. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Illei PB; Ladanyi M; Rusch VW; Zakowski MF Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646 [TBL] [Abstract][Full Text] [Related]
15. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727 [TBL] [Abstract][Full Text] [Related]
16. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis. Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350 [TBL] [Abstract][Full Text] [Related]
17. Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma. Fiegl M; Kaufmann H; Zojer N; Schuster R; Wiener H; Müllauer L; Roka S; Huber H; Drach J Hum Pathol; 2000 Apr; 31(4):448-55. PubMed ID: 10821492 [TBL] [Abstract][Full Text] [Related]
18. Role of serial pleural biopsies in the diagnosis of pleural effusions. Suri JC; Goel A; Gupta DK; Bhatia A Indian J Chest Dis Allied Sci; 1991; 33(2):63-7. PubMed ID: 1791027 [TBL] [Abstract][Full Text] [Related]
19. The utility of fluorescence in-situ hybridization in the diagnosis of malignant pleural effusion. Fiegl M Curr Opin Pulm Med; 2005 Jul; 11(4):313-8. PubMed ID: 15928498 [TBL] [Abstract][Full Text] [Related]
20. Serous effusions in malignant lymphomas: a review. Das DK Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]